Substanzen · Cathinon-Derivate
α-PVP
- Bevorzugter Name
- α-PVP
- IUPAC-Name
- 1-phenyl-2-pyrrolidin-1-ylpentan-1-one
- CAS-Nummer der Stammverbindung (Referenz)
- 14530-33-7
- Summenformel
- C15H21NO
- Molekulargewicht
- 231.33 g/mol
- InChIKey
- YDIIDRWHPFMLGR-UHFFFAOYSA-N
- PubChem
- CID 11148955
- Quelle
- PubChem
- Geprüfte Synonyme und Katalogkürzel
-
alpha-PVP a-PVP aPVP alpha-pyrrolidinopentiophenone O-2387
Passende Artikel im aktuellen Shop-Katalog
Geprüftes Pharmakologie- & Toxikologie-Dossier
alpha-PVP (alpha-Pyrrolidinovalerophenone / alpha-Pyrrolidinopentiophenone)
Rezeptor-Telemetrie & Wirkmechanismus
One of the most potent dopamine-norepinephrine reuptake inhibitors (NDRIs) characterized in vitro: high lipophilicity from the pyrrolidine ring drives rapid blood-brain barrier permeation, yielding DAT IC50 = 12.8–19.7 nM (Ki = 22.2 nM) and NET IC50 = 14.2–46 nM (Ki = 122 nM) with zero substrate release and negligible SERT inhibition (IC50 > 10,000–57,000 nM; DAT/SERT ratio > 781–2,900). Neurochemical and cardiovascular actions reflect primarily the (S)-enantiomer.
Biotransformation & Active Metabolites
Metabolized by hepatic CYP2B6, CYP2D6, CYP2C19, and CYP3A4 primarily to 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-ol (OH-alpha-PVP) and 2''-oxo-alpha-PVP lactam. Human elimination half-life is ~2.1 hours, with clinical BP/HR peaking at 40 minutes.
Zeitliche Pharmakokinetik
Fierce, razor-sharp catecholaminergic rush marked by intense psychomotor stimulation, hyper-vigilance, compulsive repeated exposure cravings, strong peripheral vasoconstriction, and rapid escalation into agitation and paranoia.
- Onset 2–20 minutes oral
- Peak Window 1–2.5 hours (clinical cardiovascular peak at 40–60 minutes)
- Total Window 2–6 hours (clinical subjective duration 3–5 hours)
- Residual / Half-Life 4–12 hours of insomnia, adrenergic tension, anxiety, and crash; human elimination half-life is ~2.1 hours.
Extremely steep dose-response curve: threshold starts at 1 mg, common oral range is 10–25 mg, and exceeding 40–50 mg (or binge repeated exposure) carries a documented high rate of excited delirium, paranoid psychosis, hyperthermia (40–41 °C), rhabdomyolysis, acute renal failure, and cardiac arrest.
Quantitatives Wirkungsspektrum (Literaturdaten)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
1 mg
Subtle increase in alertness, vigilance, and wakefulness.
Faint adrenergic crispness.
5–10 mg
Brisk mental energy, task focus, talkativeness, and modest mood lift.
Noticeable elevation in heart rate and blood pressure, dry mouth, and appetite suppression.
10–25 mg
Intense psychomotor rush, ego inflation, heightened libido, rapid thought acceleration, and strong urge to redose.
Marked tachycardia, systolic/diastolic hypertension peaking around 40–60 minutes, sweating, jaw clenching, and vasoconstriction.
25–40 mg (CAHMA strong: 25–50 mg)
Forced, jittery stimulation, restless tremors, hyper-vigilant anxiety, thought loops, and paranoid suspicion.
Severe peripheral vasoconstriction, muscle spasms, restless legs, bruxism, chest tightness, and hyperthermia.
40–50+ mg
Acute paranoid psychosis, terrifying hallucinations, violent agitation, and excited delirium.
Life-threatening hyperthermia (40–41 °C), rhabdomyolysis, acute kidney failure, myoclonus, seizures, cerebral hemorrhage, and myocardial infarction.
Wechselwirkungsmatrix — Niemals kombinieren
Lebensgefahr — Niemals kombinieren
12.8 nM DAT and 14.2 nM NET blockade combined with MAO inhibition causes immediate, fatal hypertensive crisis, stroke, and hyperpyrexia.
Extreme synergistic tachycardia, vasospasm, hyperthermia, rhabdomyolysis, seizures, and cardiac arrest.
Tramadol triggers convulsions; opioids risk fatal respiratory depression once alpha-PVP's ~2.1-hour half-life clears.
Hohes Risiko — Vermeiden
Worsens dehydration, hyperthermia, and rhabdomyolysis while masking lethal depressant intoxication.
High probability of triggering acute psychotic delirium, extreme panic, and uncontrolled behavioral crises.
Vorsicht / Abschwächung
Slows hepatic oxidation of alpha-PVP, raising blood levels toward the >100 ug/L clinical intoxication and >300 ug/L overdose range.
Strongly provokes paranoid delusions and severe tachycardia.
Isomeren- & Strukturvergleich
alpha-PVP is the sharpest, most noradrenergically intense benchmark of the pyrovalerone family (NET IC50 14.2 nM vs. 41.4 nM for alpha-PiHP and 60–935 nM for MDPHP). Compared to 6-carbon homologue alpha-PHP, alpha-PVP has a slightly shorter total window (2–6 h vs. 2–8 h) and shorter after-effects (4–12 h vs. up to 48 h), while hitting with a harsher cold adrenergic edge. Compared to NEP and Hexen, alpha-PVP is ~2.4–10x more potent at DAT/NET.
Stabilität & Lagerung
Form: White or off-white odorless crystalline powder or crystals as the hydrochloride salt (mp ~161.3 °C; freebase mp ~173 °C). · HCl salt is soluble in ethanol (~20 mg/mL), PBS (pH 7.2, ~10 mg/mL), DMSO (~10 mg/mL), and DMF (~3 mg/mL).
Store dry and tightly sealed away from light and heat.
Cross-Tolerance & Dependence Profile
Very high addiction liability due to rapid blood-brain barrier entry and ~2.1-hour half-life. Cross-tolerant with alpha-PHP, alpha-PiHP, MDPHP, NEP, and cocaine (3–7 days to halve, 1–2 weeks to baseline).
Chemische Struktur und Molekülprofil
α-PVP (1-phenyl-2-pyrrolidin-1-ylpentan-1-one) ist eine Referenzverbindung aus der Stoffklasse Cathinon-Derivate mit der Summenformel C15H21NO und einer molaren Masse von 231.33 g/mol. Die Stammverbindung wird unter der CAS-Nummer 14530-33-7 sowie in der NCBI-PubChem-Datenbank unter CID 11148955 geführt (Standard-InChIKey: YDIIDRWHPFMLGR-UHFFFAOYSA-N). Diese Verbindung teilt ihre Summenformel (C15H21NO) mit Konstitutions- oder Positionsisomeren; die eindeutige Identifizierung erfolgt über den vollständigen IUPAC-Namen und die CAS-Nummer (14530-33-7).
Quellen
- PubChem — PubChem (2026-11-12)
Referenztoxikologie und Sicherheitsprofil
Laut dokumentierten Referenzdaten (PubChem / PsychonautWiki, CC BY 4.0) gehört α-PVP zur chemischen Klasse Cathinone, Substituted cathinones, Substituted pyrrolidines. Toxikologische Hinweise (PsychonautWiki): die genaue toxische Schwelle ist in der Fachliteratur nicht festgelegt. Abhängigkeitspotenzial (PsychonautWiki): hohes Potenzial für Toleranz- und Abhängigkeitsentwicklung. Dokumentierte Kreuztoleranz: dopamine, stimulant. Beim Umgang im Labor sind geeignete persönliche Schutzausrüstung und das Sicherheitsdatenblatt (SDB) zu beachten.
Quellen
- PubChem — PubChem (2026-11-12)
Analytischer Verwendungszweck und Laborhinweis
Dieses Datenblatt dient ausschließlich der chemischen, analytischen und toxikologischen Dokumentation. Das Material ist nicht für den menschlichen Verzehr bestimmt. Ein Forschungshinweis begründet keinen Rechtsstatus.
Quellen
- Gesetze im Internet — Neue-psychoaktive-Stoffe-Gesetz (NpSG) & BtMG — Bundesministerium der Justiz (2026-11-12)